. In addition, influenza A viruses have a reservoir in birds and pigs, from which pandemic viruses with novel HA and NA proteins can emerge. There is little pre-existing immunity against these emergent viruses in the human population, and the available vaccines are unlikely to protect against such strains. Although antiviral drugs can be a first line of defence in the case of an emerging pandemic virus, the number of antiviral drugs that can be used for prophylaxis and therapeutic treatment of severe infections is limited, and emerging antiviral resistance is a continuing problem 2 . Therefore, understanding the molecular mechanisms of influenza virus replication is crucial for the development of new antiviral drugs
.
Influenza viruses contain a single-stranded negativesense RNA genome that consists of eight segments in influenza A and influenza B viruses and seven segments in influenza C viruses 3 . In all three species, the viral RNA (vRNA) genome segments form viral ribonucleoprotein (vRNP) complexes in which the 5′ and 3′ termini of the vRNA are bound by a heterotrimeric RNAdependent RNA polymerase, and the rest of the vRNA associates with oligomeric nucleoprotein (NP) 4, 5 (FIG. 1a) .
Structural models that are based on cryoelectron microscopy (cryo-EM) imaging of native vRNPs show that the vRNP is an antiparallel double helix of NP-coated vRNA that contains a polymerase at one end and an NP loop at the other end 6, 7 . The influenza virus RNA polymerase consists of three subunits: polymerase basic 1 (PB1) and PB2 are present in all influenza viruses, whereas the third subunit is polymerase acidic (PA) in influenza A and influenza B viruses, and polymerase 3 (P3) in influenza C viruses 4, 5 (FIG. 1b) . Following viral infection, the vRNPs are transported into the nucleus of the host cell, where the RNA polymerase carries out both transcription of viral genes and replication of vRNA in the context of the vRNP 8
. Transcription is a primer-dependent process that produces mRNAs with a 5′-cap and a 3′ poly(A) tail. The influenza virus polymerase does not have inherent capping activity and relies on the capped RNAs of the host as cap donors 9 . In a process called cap-snatching, the viral polymerase uses its PB2 capbinding domain to capture the 5′-cap of nascent host capped RNAs, and the PA (or P3, in the case of influenza C viruses) endonuclease domain cleaves the capped RNA 8-14 nucleotides downstream of the cap structure [10] [11] [12] . These capped RNA fragments are then used as primers to initiate transcription of viral mRNAs. In contrast
Antigenic variation
Changes in the antigenicity of a protein of interest (here, the haemagglutinin and neuraminidase proteins) owing to antigenic drift or shift.
Haemagglutinin
(HA). A type I integral membrane glycoprotein of influenza viruses that binds to cell surface receptors in the host and facilitates fusion between the viral envelope and endosomal membrane. It is the main antigen that is targeted by the humoral immune response of the host. 
Cap-snatching
A process in which a cellular capped RNA is cleaved a few nucleotides downstream of the 5′-cap by an endonuclease activity that is encompassed within a viral RNA-dependent RNA polymerase.
to transcription, replication is primer independent and proceeds through a complementary RNA (cRNA) replicative intermediate. Progeny vRNPs are exported from the nucleus and trafficked to the cell membrane to be incorporated into new virions
Until recently, a lack of high-resolution structural information about the influenza virus RNA polymerase greatly hampered our understanding of influenza virus transcription and genome replication at the molecular level. The RNA polymerases of negative-sense RNA viruses have been refractory to structural analyses, primarily owing to their large size and low expression levels in recombinant systems and, in the case of influenza viruses, their multisubunit nature 13, 14 . Recent developments in the expression and purification of large proteins and macromolecular complexes, combined with improved methods for the structural analysis of proteins, have resulted in high-resolution RNA polymerase structures for influenza A, influenza B and influenza C viruses, as well as for other negative-sense RNA viruses, including La Crosse virus (a bunyavirus) and vesicular stomatitis Indiana virus (VSIV; a rhabdovirus) [15] [16] [17] [18] [19] . These novel structures provide unprecedented insights into the molecular mechanisms of action of these polymerases. In this Review, we focus on these novel structural insights, in particular with reference to subunit and domain organization, and describe how these insights have advanced our understanding of viral transcription,
Box 1 | Influenza A virus life cycle
Viral infection is initiated when a virion binds to cell surface receptors that contain sialic acid, followed by endocytosis of the virion (see the figure). After fusion of the viral and endosomal membranes, the viral ribonucleoproteins (vRNPs) are released into the cytoplasm and then transported into the nucleus. In the nucleus, the viral RNA-dependent RNA polymerase replicates the single-stranded negative-sense viral RNA (vRNA) genome segments by copying them into complementary RNAs (cRNAs), which are positive-sense RNAs that form complementary RNPs (cRNPs) and act as templates for the production of vRNAs. The viral RNA polymerase also carries out transcription of the vRNA segments into mRNAs, which are 5′ capped and 3′ polyadenylated. Viral mRNA is exported to the cytoplasm for translation by cellular mechanisms. Newly synthesized viral RNA polymerase subunits (polymerase basic 1 (PB1), PB2 and polymerase acidic (PA)) and nucleoprotein (NP) are imported into the nucleus and bind to vRNA genomic segments and cRNAs to assemble vRNPs and cRNPs, respectively. Following nuclear export, progeny vRNPs are transported across the cytoplasm on recycling endosomes in a RAB11-dependent manner to the cell membrane, where the assembly of progeny virions takes place. Mature virions incorporate a substantial amount of host proteins 73 and are released by budding. Auxiliary viral proteins (PB1-F2, PB1-N40, PB2-S1, PA-X, PA-N155, PA-N182, M42 and NS3) have been detected in infected cells but are not known to be incorporated into progeny virions; these proteins are not shown 130 . HA, haemagglutinin; M, matrix protein; NA, neuraminidase; NEP, nuclear-export protein; NS1, non-structural protein 1. replication and host adaptation. Finally, we discuss how such structural data could inform the development of new prophylactic antivirals or treatments for influenza virus infections.
The RNA synthesis machine Viral polymerase structure. The past decade witnessed the emergence of high-resolution structural information about fragments of the three subunits of the influenza virus polymerase [10] [11] [12] [20] [21] [22] [23] [24] . Moreover, cryo-EM of the polymerase heterotrimer in isolation or as part of a vRNP revealed that the polymerase has a globular structure 6, 7 . However, these structures provided limited information about the arrangement of the subunits in the polymerase heterotrimer. This changed substantially with the availability of high-resolution X-ray crystallography structures of the complete polymerase hetero trimers of the bat influenza A virus and human influenza B and influenza C viruses 16, 18, 19 (FIG. 1b) . In addition, cryo-EM was used to obtain the structure of In the vRNP, the 5′ and 3′ termini of the genomic negative-sense viral RNA (vRNA) segment are bound by a heterotrimeric RNA-dependent RNA polymerase, and the rest of the vRNA is coated by nucleoprotein (NP). The complex is twisted into an antiparallel double helix, the structure of which is maintained by contacts between NP monomers. The vRNA forms a loop at the end opposite the polymerase-bound end 6, 7 . b | Front and side views of the influenza A virus (Protein Data Bank (PDB) entry 4WSB), influenza B virus (PDB entry 4WSA) and influenza C virus (PDB entry 5D98) RNA polymerase structures, shown in surface (top and middle rows) and cartoon model (bottom row) representations. The three subunits, polymerase basic 1 (PB1), PB2 and polymerase acidic (PA; or polymerase 3 (P3) for influenza C virus), are coloured in purple, pink and green, respectively. The PB2 cap-binding domain (PB2-cap), PB2 627-domain (PB2-627), PA and P3 endonuclease domain (PA-endo and P3-endo), and PA and P3 C-terminal domain (PA-C and P3-C) are indicated. In the influenza A and influenza B virus polymerase structures, the 5′ and 3′ termini of a vRNA are shown in dark grey and yellow, respectively; by contrast, the influenza C virus polymerase is in the apo form (unbound to RNA). In the influenza A virus polymerase structure, the cap-binding and endonuclease domains face each other, configured for cap-snatching (left, bottom row). In the influenza B virus polymerase structure, the cap-binding domain is rotated to face the centre of the polymerase, which is consistent with the insertion of the capped primer into the active site through the product exit channel (middle, bottom row). In the influenza C virus polymerase structure, the cap-binding pocket of PB2 is blocked, and the P3 endonuclease domain is oriented away from the PB2 cap-binding domain, incompatible with cap-snatching (right, bottom row).
Host range determinant
A characteristic of a pathogen that enables it to replicate in a particular host.
Panhandle structure
A double-stranded RNA structure that is formed by the conserved 5′ and 3′ RNA termini of negative-sense viral RNA genomes.
Apo form
A protein with no ligand bound.
an H5N1 avian influenza virus polymerase complex that is composed of PB1, PA and an N-terminal fragment of PB2 at a resolution of 4.3 Å
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. The X-ray crystallography structures of the complete polymerase heterotrimer revealed that the PB1 subunit is the centre of the polymerase (FIGS 1b, 2a, b) . PB1 contains the pre-A motif (also known as motif F) and motifs A-E, which are characteristic of RNA-dependent RNA polymerases 26 (FIG. 2a) . Accordingly, PB1 has the canonical right-hand-like fold, which has subdomains known as the fingers (including fingertips), palm and thumb, but with additional N-terminal and C-terminal extensions that facilitate interactions with the PA (or P3, in influenza C viruses) and PB2 subunits, respectively (FIG. 2b) . PB1 is sandwiched by the N-terminal endonuclease domain and the large C-terminal domain of the PA (or P3) subunit (FIGS 1b, 2b, c) . A long linker connects the two PA (or P3) domains and wraps around the external side of the PB1 fingers and palm subdomains. PB2 consists of several domains (FIGS 1b, 2d) . The N-terminal third of PB2, which includes the lid domain, interacts with PB1, making contacts mostly with the PB1 thumb and C-terminal extension. The arrangement of the domains within the remaining two thirds of PB2 differs substantially in the influenza A and influenza B virus polymerase structures compared with their arrangement in the influenza C virus polymerase, which indicates that these regions form flexible domains (Supplementary information S1 (movie)). These flexible regions include the mid domain, the cap-binding domain, the cap-627 linker, the so-called 627-domain (named after amino acid residue 627, which is a host range determinant of influenza viruses 27 ; see below) and the C-terminal nuclear-localization signal (NLS) domain (FIG. 2d) . The mid and linker domains form one unit that is referred to as the mid-link 28 . Overall, the viral polymerase can be viewed as a complex that is made up of a polymerase core -consisting of PB1, the C-terminal domain of PA (or P3) and the N-terminal region of PB2 -and flexible peripheral appendices that are formed by the PA (or P3) endonuclease domain and the PB2 cap-binding, mid-link, 627-and NLS domains.
Promoter binding. The highly conserved sequences that are present at the termini of each vRNA genome segment have the potential to form a partially double-stranded panhandle structure 29 . The polymerase needs to associate with the 5′ end of the vRNA template to bind to and cleave host capped RNA, as well as to initiate transcription at the 3′ end of the vRNA template [30] [31] [32] [33] [34] . These observations led to the proposal that the vRNA promoter is formed by the 5′ and 3′ terminal sequences of the vRNA segments 31 . The structures of the influenza A and influenza B virus RNA polymerases were obtained in the presence of short RNAs that mimic the 5′ and 3′ terminal vRNA sequences, thus revealing how the vRNA promoter is bound to the polymerase. The crystal structures show that nucleotides 1-10 of the 5′ end of the vRNA form a compact stem-loop structure (also known as the hook structure) that inserts into a deep pocket at the interface of the PB1 fingers and the PA C-terminal domain (FIGS 1b, 2b, c) . Several amino acid residues from both PB1 and PA create a highly specific and strong interaction 13, 18, 19, 35 . Nucleotides 1-9 of the 3′ end of the vRNA bind in a nearby binding site on the surface of the poly merase, and amino acid residues from all three polymerase subunits contribute to this association. These findings are consistent with UV-crosslinking experiments, which showed that all three subunits intimately interact with the vRNA termini 31, 36 . The distal part of the vRNA promoter forms a double-stranded structure that involves nucleotides 11-16 of the 5′ end and nucleotides 10-15 of the 3′ end, and in the polymerase crystal structures, this double-stranded structure projects away from the body of the polymerase. The overall arrangement of the vRNA promoter is consistent with vRNA promoter models that are derived from mutagenic studies, which predicted a 5′ hairpin-loop and base-pairing in the distal region 31, 32, 37, 38 . An RNA secondary structure similar to the vRNA promoter has been predicted for the cRNA replicative intermediate and is called the cRNA promoter 39, 40 . Although the 5′ end of the cRNA differs in sequence from the vRNA 5′ end (being the complement of the vRNA 3′ end), it forms a similar hook structure and is bound by the influenza B virus polymerase at the same site as the vRNA 5′ end 28 .
Conformational rearrangements of the viral polymerase.
Different conformations of the polymerase can be observed in the crystal structures of the RNA-free (apo form) influenza C virus polymerase and the vRNA promoter-bound influenza A and influenza B virus poly merases (FIG. 1b) . Whereas the polymerase core changes little when vRNA is bound, the peripheral C-terminal two-thirds of PB2 (including the cap-binding, mid-link, 627-and NLS domains) and the N-terminal PA (or P3) endonuclease domain undergo major rearrangements (Supplementary information S1 (movie)). In the apo structure of the influenza C virus polymerase, the PB2 cap-binding domain is immobilized by several interdomain interactions that involve the PB1 palm subdomain, and the cap-binding pocket is occluded by a part of PB2. The P3 endonuclease domain is located on the side of the fingers subdomain of PB1, with the PB2 NLS domain packing against the endonuclease domain. This arrangement of the cap-binding and endonuclease domains is incompatible with cap-snatching activity 16, 28 . By contrast, in the vRNA promoter-bound influenza A and influenza B virus polymerase structures, the PB2 cap-binding and PA endonuclease domains are oriented in a way that is compatible with cap-snatching (FIG. 1b) , consistent with previous observations that cap-snatching is activated by the binding of the polymerase to vRNA 30, 34 . In this arrangement, the cap-binding domain makes little contact with the other domains, so it can rotate freely in situ, whereas the endonuclease domain is stabilized by a motif that interacts with the PB1 C terminus and the PB2 N terminus. In addition, the NLS domain of PB2 no longer contacts the PA endonuclease domain and has instead moved with the PB2 627-domain to a site that The conformations captured by X-ray crystallography most probably represent the polymerase in two different functional states. The apo form of the influenza C virus polymerase corresponds to a transcriptionally inactive state and may represent the structure of the newly assembled polymerase. However, a structure of the influenza B virus polymerase in complex with 5′ cRNA shows an arrangement of peripheral domains that is similar, although not identical, to the apo structure of the influenza C virus polymerase 28 . Therefore, this conformation may also be relevant for a polymerase engaged in the primer-independent cRNA-to-vRNA step of genome replication, which does not require cap-snatching. By contrast, the structures observed in the presence of vRNA represent the polymerase in a transcription pre-initiation state, with the cap-binding and endonuclease domains aligned such that the polymerase could bind and cleave host capped RNA (FIG. 1b) . Structural and biophysical characterization of the polymerase in solution, with and without bound RNA, suggests that multiple conformations exist in equilibrium 16, 28 . Thus, the influenza virus RNA polymerase is inherently flexible. The nature of the RNA present (that is, whether vRNA or cRNA, and whether a 5′ and/or a 3′ end) influences the equilibrium, and a particular conformation may further be stabilized through interactions with other viral or host factors (see below), which may preferentially promote a particular function of the polymerase 16, 28 . Therefore, it is possible that vRNAbound polymerase could also exist in a transcriptionally inactive state, for example in vRNPs packaged into virions and in vRNPs that are in transit from the host cell nucleus to the plasma membrane.
The polymerase active site. The polymerase active site is located at the edge of a large central cavity that is formed by PB1 and the N terminus of PB2 (REFS 16, 18, 19) . The active site can be accessed through several channels (FIG. 2e) . The template exit channel is located on the same side of the polymerase as the template entry channel. In the absence of vRNA, the PA endonuclease and PB2 cap-binding domains are arranged such that no cap-snatching can take place, owing to the relative orientation of the domains and blocking of the cap-binding pocket of PB2. f | A model of the RNA polymerase in the transcription pre-initiation state, which shows the conformational rearrangement of the flexible peripheral PB2 cap-binding, PB2 627-and PA endonuclease domains in comparison to their positions in the inactive state. The product exit channel is defined by the path that the capped RNA primer takes when its 3′ end is inserted into the active site. In the central cavity, the priming loop, which is a β-hairpin in the case of the influenza virus polymerase, protrudes from the PB1 thumb subdomain towards the active site. The U-stretch near the 5′ end of the vRNA template acts as a poly(A) signal. In this pre-initiation state, in the presence of vRNA, a major rearrangement of the flexible domains of PB2 and a shift in the position of the PA endonuclease domain result in an alignment of the PB2 cap-binding and PA endonuclease domains that is compatible with cap-snatching. NP, nucleoprotein. 
PB2-627
Cleavage
Helicase
An enzyme that catalyses the unwinding and separation of double-stranded DNA or RNA using energy from ATP hydrolysis.
De novo initiation
The initiation step of nucleic acid synthesis that occurs by means of a primer-independent mechanism.
The putative template entry channel that leads from the site of 3′ vRNA binding into the active site is lined by conserved amino acid residues from all three subunits, and the NTP entry channel is made up of highly conserved basic amino acids from PB1. In contrast to positive-sense RNA viruses, influenza viruses lack a helicase, and the template and product RNA strands are separated before they exit the polymerase. Potentially, an element of PB2 called the lid domain (FIG. 2d) could be responsible for separating the two strands, which seem to clash with this element when modelled into the available crystal structures 19 . The putative template exit channel is located on the same side of the polymerase as the template entry channel, and it has been identified by comparing the influenza virus RNA polymerase structure to that of the La Crosse virus RNA polymerase, which shows a more obvious channel for template exit 15 . The close proximity of the template entry and exit channels on the same side of the polymerase could facilitate replication of the RNA genome with minimal disruption of the vRNP complex (see below). The product exit channel is likely to be defined by the path that the capped RNA primer takes when its 3′ end is inserted into the active site (FIG. 2f) . An important feature of the central cavity is the priming loop (a β-hairpin structure, in the case of the influenza virus polymerase), which protrudes from the PB1 thumb subdomain towards the active site (FIG. 2a,f) and may support the sugar-base of the first NTP during de novo initiation, as observed in other RNA-dependent RNA polymerases 19, [41] [42] [43] . A recent study has shown that the priming loop is important for the initiation of primer-independent replication on the vRNA template 44 (see below).
Pol II pausing
(Cellular DNA-dependent RNA polymerase II pausing). A control step in gene transcription, in which Pol II pauses at certain sites and requires specific stimuli and elongation factors to overcome this pausing block and enter productive elongation.
Models for transcription and replication
Transcription. After vRNPs reach the nucleus, the resident polymerase -that is, the polymerase that is bound to the vRNA termini in the vRNP -synthesizes 5′-capped and 3′-polyadenylated viral mRNA (FIG. 3a) .
For this process, the viral polymerase requires primers that are 5′-capped RNA fragments derived from nascent host capped RNAs. Accordingly, viral transcription is sensitive to actinomycin D, a transcription inhibitor, and to α-amanitin, an inhibitor of cellular DNA-dependent RNA polymerase II (Pol II). Host small nuclear RNAs (snRNAs), small nucleolar RNAs (snoRNAs) and promoter-associated capped small RNAs (which are generated by Pol II pausing during transcription initiation) are the preferred substrates for cap-snatching, rather than mRNAs or pre-mRNAs [45] [46] [47] . Cap-snatching is carried out by the viral polymerase when it is in a transcription pre-initiation state (as illustrated by the influenza A and influenza B virus polymerase structures), with the PB2 cap-binding and PA endonuclease domains aligned such that the polymerase can bind to and cleave host capped RNA. After cleavage of the capped RNA, the 3′ end of the capped primer must transfer from the endonuclease active site into the polymerase active site through the product exit channel. This transfer is likely to be facilitated by rotation of the cap-binding domain, as observed in one of the influenza B virus polymerase structures 19 ( FIGS 1b,3a) . Concomitantly, the 3′ end of the vRNA template must move from its binding site near the surface of the polymerase into the polymerase active site through the template entry channel (FIG. 3a) . Currently, it is unclear how this is triggered, but an equilibrium might exist between conformations with the 3′ end at the surface or in the active site. The vRNA 3′ end might be stabilized in the active site by interactions between the capped RNA primer and the 3′ end of the vRNA template or by binding of an initiating nucleotide. Transcription initiation takes place through the addition of a G or C residue to the 3′ end of the capped primer, directed by the penultimate C residue (C2) or the G residue at position 3 (G3) in the vRNA template. In infected cells, there is a preference for transcription initiation with primers with a 3′-CA end, but the structural basis for this sequence specificity remains unknown 48, 49 . The four conserved residues at the tip of the priming loop in the polymerase active site are redundant for this process, as they can be deleted without affecting transcription initiation 44 . Currently, it is unknown how the polymerase copies the vRNA template in the context of the vRNP. It is likely that only local restructuring of the NP helix takes place when the polymerase 'pulls' the template vRNA from the NP helix into its active site. The proximity of the template entrance and exit channels is compatible with a model in which template vRNA is progressively dissociated from NP, translocated through the entrance channel into the polymerase active site and then re-associated with NP at the exit channel (FIG. 3a) . Elongation continues in a template-dependent manner by pulling the vRNA template through the polymerase active site until a 5-7-nucleotide U-stretch, which is located 16 nucleotides from the 5′ end of the vRNA template, reaches the active site. Stuttering of the polymerase on the U-stretch leads to the repeated incorporation of AMP and the production of a poly(A) tail (FIG. 3a) . Evidence for the stuttering mechanism has been provided by replacement of the U-stretch with an A-stretch, which resulted in the generation of mRNAs with a poly(U) tail 50, 51 . Although the exact mechanism that triggers stuttering is unclear, it has been proposed to involve steric hindrance caused by the 5′ end of the vRNA template, which remains associated with the transcribing polymerase 31, 33, 38 . Return of the already copied 3′ end of the vRNA template to its original position near the surface of the polymerase . The 3′ end of the negative-sense viral RNA (vRNA) template (orange) also inserts into the active site through the template entry channel, and NTPs enter through the NTP entry channel. Transcription is initiated by the addition of an NTP to the 3′ end of the capped primer, complementary to the second (shown) or third residue in the vRNA template. During elongation, product and template are separated, and they exit through their respective exit channels. As the template is pulled into the active site, viral nucleoprotein (NP) detaches from the entering vRNA, translocates via the surface of the polymerase and joins the vRNA template as it emerges through the template exit channel. The 5′-cap of the mRNA product is released from the PB2 cap-binding domain as the polymerase enters elongation 52 . Termination is achieved through polyadenylation (light blue) that occurs as the result of repeated copying of the U-stretch (red) of the vRNA template 50, 51 . The 5′ end (grey) of the vRNA remains bound to its binding site formed by amino acid residues from PB1 and PA, and it may be stabilized by base-pairing with the 3′ end of the vRNA, which rebinds at its binding site near the surface of the polymerase during elongation. b | Model for the synthesis of complementary RNA (cRNA; green), as the first step in replication of a vRNA segment. The polymerase is shown in the same conformation as in part a. Initiation is a primer-independent process, so there is no primer cleavage step. The 3′ of the vRNA template inserts into the active site, and NTPs enter through the NTP entry channel. De novo initiation occurs at the first residue of the vRNA template (called terminal initiation), and the initiating nucleotide is stabilized by the priming loop of the polymerase 19, 44, 57 . During elongation, product and template are separated, and they exit through their respective exit channels. NP translocates via the surface of the polymerase to join the vRNA template as it emerges through the template exit channel. The 5′ end of the cRNA product is bound by a second polymerase as it emerges from the product exit channel, and the rest of the cRNA associates with NP to assemble complementary ribonucleoprotein (cRNP) complexes. In the termination stage, the 5′ end of the vRNA template is released from its binding site and is pulled through the polymerase active site, while the 3′ end rebinds at the surface of the polymerase. c | Model for vRNA synthesis, as the second step in replication of the viral genome. The polymerase is depicted in the inactive state, which is consistent with the conformation of the polymerase bound to the 5′ end of cRNA 28 . Again, there is no primer cleavage step, as there is no primer required. For replication initiation to take place, the polymerase needs to interact with a trans-activating polymerase 56 . The 3′ end of the cRNA template inserts into the active site, and NTPs enter through the NTP entry channel. De novo initiation occurs at the fourth and fifth residue of the cRNA template (called internal initiation) without the participation of the priming loop 19, 44, 57 . The resulting pppAG dinucleotide relocates to the 3′ end of the cRNA template (not shown) and is elongated by the polymerase. Elongation and termination proceed as described above for cRNA synthesis. The 5′ end of the vRNA product is bound by the trans-activating polymerase, and the rest of the vRNA associates with NP to assemble viral ribonucleoprotein (vRNP) complexes. Note that an alternative model, involving a trans-acting polymerase, has also been proposed for cRNA-to-vRNA replication (not shown) 7, 66 . PB2-627, 627-domain of the PB2 subunit.
and its base-paring with the 5′ end potentially help to 'lock' the 5′ end in its binding site, thereby preventing its release during polyadenylation (FIG. 3a) .
At the point of transcription initiation, the 5ʹ cap is associated with the PB2 cap-binding domain. However, as the polymerase enters elongation, the cap is released from the PB2 cap-binding domain 52 (FIG. 3a) .
Subsequently, the 5′ cap is likely to be bound by the host nuclear cap-binding complex, triggering the assembly of the viral mRNA into a host messenger ribonucleoprotein (mRNP)-like structure 53, 54 .
Replication. Replication is a two-step, primer-independent process. In the first step of replication, incoming vRNPs carry out the synthesis of cRNA, which is a replicative intermediate (FIG. 3b) . Biochemical data show that the resident polymerase is capable of catalysing cRNA synthesis: vRNPs that are isolated both from purified virions and from infected cells can catalyse the generation of cRNA in a primer-independent manner in vitro 55, 56 . Similar to transcription initiation, replication initiation requires the translocation of the 3′ terminus of a vRNA into the active site. Next, a pppAG dinucleotide is formed on residues U1 and C2 of the vRNA 3′ end (a process called terminal initiation) 57 . As is the case for other de novo-initiating RNA polymerases, the formation of the dinucleotide on the terminus of the RNA template is dependent on structural support from a priming loop 19, 44 . Elongation presumably proceeds in a manner that is similar to that described for mRNA synthesis, with minimal disruption of the vRNP structure. However, in contrast to transcription, during the termination of cRNA synthesis, the 5′ end of the vRNA template must be released from its binding pocket to be copied (FIG. 3b) . It is currently unclear how this difference between mRNA and cRNA termination is achieved.
The cRNA product assembles into a complementary ribonucleoprotein (cRNP) complex, which is a vRNP-like structure with a polymerase bound at the 5′ and 3′ termini and NP that associates with the body of the cRNA. Negative-stain EM of isolated cRNPs revealed a twisted, double-helical arrangement of the cRNA-NP complex, very similar to that of the vRNP 56 . Assembly of the cRNA into a cRNP probably starts as soon as the 5′ end emerges from the product exit channel and is bound by a second, newly synthesized polymerase. The second polymerase then recruits the first NP through polymerase-NP interactions. However, subsequent NPs are recruited through groove and tail-loop interactions between NP monomers in solution and cRNA-bound NPs [58] [59] [60] [61] . Several mechanisms, including phosphorylation and interactions with host factors, such as importins, have been proposed to maintain NP in a monomeric form before it is incorporated into an oligomer of NPs within the RNP [62] [63] [64] [65] . A similar detailed mechanism of genome replication, involving binding of polymerase to the 5′ end of the emerging nascent replication product and subsequent binding of NP, has been proposed for bunyaviruses 15 .
In the second step of replication, cRNA acts as a template for vRNA synthesis (FIG. 3c) . In contrast to replication on a vRNA template, replication initiation on a cRNA template occurs on residues U4 and C5 (a process called internal initiation) 57 . The pppAG dinucleotide product is then aligned to residues U1 and C2 of the cRNA 3′ terminus to enable elongation into a full-length copy of the cRNA. Recent data show that the full-length priming loop is not required for internal initiation on a cRNA template, possibly because the 3′ UCG overhang contributes to the stabilization of the template-dinucleotide complex 44 . However, replication from the cRNA template is critically dependent on the presence of a second polymerase in addition to the resident polymerase. In particular, cRNPs that were isolated from infected cell lysates were inactive in vitro unless 'extra' polymerase was added 56 . Interestingly, this second polymerase does not need to be catalytically active, which suggests that it fulfils a role that does not involve RNA synthesis and that it is trans-activating rather than trans-acting 56 . It is tempting to speculate that the trans-activating polymerase induces a conformational rearrangement in the resident polymerase that favours the transfer of the cRNA 3′ terminus to the active site and/or favours internal initiation on the cRNA 3′ terminus. Although it is not known where and how the cRNA 3′ terminus binds to the polymerase, based on the binding of the cRNA 5′ end to the influenza B virus polymerase 28 , which is similar to the binding of the vRNA 5′ end, it can be assumed that in a resting state the 3′ end of the cRNA template occupies the same site as the 3′ end of the vRNA template. In this model of vRNA synthesis, the trans-activating polymerase would also fulfil the role of the polymerase that binds to the 5′ end of the emerging nascent vRNA and recruits the first NP to start the assembly of a vRNP; this process is likely to proceed in a manner that is similar to that described for cRNPs (see above).
An alternative model for the second step of replication involves a catalytically active, trans-acting polymerase. In this model, a new polymerase, possibly associated with small viral RNA (svRNA; see below), is recruited to the resident polymerase and gains access to the 3′ terminus of the cRNA template. The 3′ terminus enters the active site of the trans-acting polymerase, and this second polymerase carries out replication initiation internally on the cRNA template as described above for the trans-activating polymerase model. However, in this trans-acting polymerase model, a third polymerase is proposed to bind to the 5′ end of the nascent vRNA to initiate the assembly of a vRNP. Genetic complementation experiments as well as the observation of branched RNPs in cryo-EM support this alternative model 7, 66 . Further studies are required to confirm whether vRNA synthesis is carried out by the resident or a trans-acting polymerase.
Regulation of transcription and replication
Regulation by viral factors. Several viral proteins have been implicated in the regulation of viral transcription and replication (FIG. 4) . In particular, NP has long been considered a factor that switches the polymerase from a transcriptase to a replicase 67, 68 . However, more recent studies challenge this view by indicating that . Polyadenylation of viral mRNA is stimulated by the host splicing factor SFPQ; viral non-structural protein 1 (NS1) and host proteins RED, SMU1, SF2, NS1-binding protein (NS1BP) and heterogeneous nuclear RNP K (hnRNP K) participate in mRNA processing 78, 79, [116] [117] [118] [119] . The host cap-binding complex (CBC) binds to the 5′ -cap of the viral mRNA once it is released by the viral RNA polymerase subunit polymerase basic 2 (PB2) 53 . vRNPs that are in close proximity to Pol II but not bound to the CTD of the Pol II large subunit carry out complementary RNA (cRNA) synthesis. cRNA acts as a template for the synthesis of negative-sense viral RNA (vRNA) genomic segments. Free viral polymerase and viral nucleoprotein (NP) are required for the assembly of cRNA and vRNA into complementary RNP (cRNP) and vRNP complexes, respectively. Host DDX39B, TATSF1 and FMR1 stimulate vRNA replication by promoting NP interactions with the viral RNA polymerase or stimulating NP recruitment to nascent viral RNA during cRNP and vRNP assembly 71, 90, 123 . Viral NS1 regulates vRNA replication by interacting with NP [74] [75] [76] [77] , and viral nuclear-export protein (NEP) promotes vRNA replication, possibly through the stimulation of small viral RNA (svRNA) synthesis [81] [82] [83] . svRNAs are implicated as viral cofactors in genome replication 85 . The cellular DNA helicase minichromosome maintenance (MCM) as well as proteins of the ANP32 family are also implicated in genome replication 120, 121 . ANP32A may contribute by recruiting a trans-activating or trans-acting polymerase to the resident cRNP-bound polymerase in a hostand PB2 627-domain-specific manner to facilitate vRNA synthesis, although the exact mechanism of its involvement remains unknown 82, 121, 122 . Importin-α (IMPα), which acts as an import factor for PB2, is proposed to have a role in transcription and replication 23, 124 . Importin 5 (IMP5; also known as RANBP5) acts as a cofactor for the nuclear import of the PB1-polymerase acidic (PA) dimer 13, 101, 103 . NXP2, nuclear matrix protein 2; PA-endo, PA endonuclease domain; PB2-cap, PB2 cap-binding domain.
Pol II large subunit CTD (Cellular DNA-dependent RNA polymerase II large subunit C-terminal domain). An unstructured, evolutionarily conserved domain at the C terminus of the largest Pol II subunit; this domain comprises tandem copies of the consensus heptapeptide YSPTSPS, and phosphorylation of these repeats is crucial for the regulation of Pol II function. the initiation of mRNA or cRNA synthesis could be stochastic, with no switch regulating the initiation of RNA synthesis 69 . In this model, newly synthesized viral polymerase and NP are required to stabilize nascent cRNA, which would otherwise be degraded by host cell nucleases. Furthermore, short genome segments (up to 76-nucleotides long), with large internal deletions but preserved 5′ and 3′ terminal sequences, were found to be efficiently transcribed and replicated in the absence of NP in cell-based transcription and replication assays 61, 70 . NP had no effect on the ratio of transcription to replication products under these conditions. However, NP has been observed to stimulate polymerase activity, and it is required for the processivity of the polymerase on long RNA templates 71, 72 . Two other viral proteins, non-structural protein 1 (NS1) and nuclearexport protein (NEP; formerly known as NS2) have also been implicated in the regulation of transcription and replication (FIG. 4) . NS1, which was recently identified as a component of the influenza virion 73 , was found to interact with NP, and several studies suggest a role for NS1 in viral RNA synthesis [74] [75] [76] [77] and the splicing of viral mRNAs 78, 79 . NEP is primarily considered to have a major role in mediating the nuclear export of progeny vRNPs 80 . However, there is also evidence for a regulatory role of NEP in viral RNA synthesis, with NEP expression leading to an increase in replication 81, 82 . This function has been linked to the requirement for NEP during the generation of 22-27-nucleotide-long svRNAs that correspond to the 5′ termini of vRNAs and are highly expressed in infected cells 83, 84 . svRNAs have been implicated as viral factors that are involved in the replication of cRNA into vRNA 85 . svRNAs might associate with a trans-acting polymerase through binding to the binding pocket that associates with the vRNA 5′ end.
Regulation by host factors. A wide range of methods, including proteomics and genome-wide RNAi-based screens, have been applied to search for host factors that are involved in viral replication 2, [86] [87] [88] [89] [90] [91] [92] [93] [94] . Targeted interaction screens using proteomics to identify host proteins interacting with the viral polymerase, NP and RNPs have also been carried out and have revealed hundreds of candidate proteins that could affect viral RNA synthesis 90, 93, [95] [96] [97] [98] [99] [100] [101] [102] [103] . However, the roles of very few of these host factors have been investigated in detail.
Viral transcription and replication are carried out in the nucleus of the infected host cell. vRNPs are targeted to the nuclear matrix or to chromatin components, where viral transcription and replication are proposed to take place 75, [104] [105] [106] [107] . Specific interactions between the influenza virus polymerase and the chromatin remodellers CHD1 and CHD6, nuclear matrix protein 2 (NXP2; also known as MORC3) and the Pol II function modulator CLE (also known as C14orf166) may play a part in targeting vRNPs to those nuclear compartments [108] [109] [110] [111] . Viral mRNA synthesis is proposed to take place in close association with host Pol II. It has been demonstrated that the viral polymerase interacts directly with the serine-5-phosphorylated form of the Pol II large subunit CTD 112, 113 . This form of the CTD is known to recruit cellular capping enzymes to cap nascent Pol II transcripts near the transcription start site 114 . The interaction of the viral polymerase with the same form of the CTD presumably facilitates access of the viral polymerase to nascent host capped RNAs (FIG. 4) . However, this interaction also brings viral mRNA synthesis close to sites of high concentrations of splicing factors and host factors that are involved in the assembly of host mRNPs, and it may therefore facilitate not only cap-snatching but also RNA processing and viral mRNP assembly 54 . Viral matrix 1 (M1), NS1 and PB2 mRNAs can be spliced 115 , a function that is carried out by the cellular splicing machinery. Cellular factors that are related to splicing, including RED (also known as RER or IK), SMU1, SF2 (also known as ASF1 or SRSF1), SFPQ (also known as PSF), heterogeneous nuclear RNP K (hnRNP K) and NS1-binding protein (NS1BP), have been identified as important for influenza virus replication [116] [117] [118] [119] . Splicing factor SFPQ interacts with vRNPs and has been shown to be important for viral mRNA synthesis by increasing the efficiency of viral mRNA polyadenylation 117 . The cellular transcriptional machinery may provide the viral polymerase with a platform inside the host cell nucleus around which not only viral mRNA synthesis and processing but also vRNA replication is organized. The minichromosome maintenance (MCM) complex is a cellular helicase that is involved in DNA replication, but also participates in Pol II elongation through an interaction with the Pol II large subunit CTD and was found to stimulate vRNA replication. MCM interacts with the PA subunit of the viral RNA polymerase and seems to stimulate the transition from de novo initiation to elongation on the vRNA template 120 . Members of the ANP32 family of proteins are implicated in multiple cellular pathways, including transcriptional regulation by chromatin remodelling, mRNA export and cell death, and were found to promote the second step of replication (that is, vRNA synthesis from a cRNA template). In particular, human ANP32A (also known as pp32) and ANP32B (also known as APRIL) were shown to interact with the viral RNA polymerase 96, 98, 121 , to upregulate vRNA synthesis from cRNA in vitro 121 and to be required for viral RNA synthesis in infected cells 93 . Importantly, ANP32A was found to underlie the species specificity (host restriction) of the influenza virus, which is mediated, in large part, by PB2 residue 627. More precisely, a difference in ANP32A between mammalian and avian cells is responsible for the suboptimal function of avian influenza virus polymerase in mammalian cells 122 . Avian influenza virus polymerase PB2 contains glutamic acid at position 627, whereas many human influenza virus polymerases have a lysine residue at this position. In comparison to its human counterpart, avian ANP32A contains 33 additional amino acids between its leucine-rich repeats and the C-terminal low-complexity acidic region. When mammalian cells expressed either avian ANP32A or human ANP32A that contained this 33 amino acid insertion, the activity of avian influenza virus polymerase was stimulated to levels similar to the activity of mammalian-adapted viral polymerase in mammalian cells. Thus, ANP32A represents a host specificity factor of the influenza virus polymerase. The requirement for ANP32 proteins during cRNA-to-vRNA replication is consistent with previous findings that linked PB2 residue 627-mediated host restriction to a block in avian influenza virus cRNP activity in mammalian cells 82 . Although the molecular mechanisms that underlie the action of the ANP32 proteins remain obscure, it is tempting to speculate that they facilitate the recruitment of the transactivating polymerase to the cRNP-resident polymerase and promote its initiation of vRNA synthesis.
Several other host factors, including the RNA helicase DDX39B (also known as BAT1 or UAP56), TATSF1 (also known as HTATSF1) and the mRNA export and translation regulator FMR1 have been reported to enhance vRNA replication by promoting either NP interactions with the viral RNA polymerase or NP recruitment to nascent vRNA and cRNA during RNP assembly 71, 90, 123 . Host importin-α isoforms have been reported to function in influenza virus RNA replication by interacting with the PB2 polymerase subunit in a host-dependent manner 124 .
Box 2 | Therapeutic applications of structural data
Most attempts to develop antivirals that target the influenza virus RNA polymerase have so far focused on the polymerase basic 1 (PB1) subunit active site, the PB2 cap-binding domain and the polymerase acidic (PA) endonuclease domain 131 . These attempts led to the discovery of compounds that act as RNA chain terminators, as mutagens or as inhibitors of the cap-snatching activity of the polymerase [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] . Structural studies of some of these compounds in complex with either the PB2 cap-binding or PA endonuclease domain have produced valuable data that are currently being used to improve the pharmacokinetic parameters of these compounds. The novel structural data about the polymerase heterotrimer will be a source for new drug discoveries. The structures have revealed the conformation of the active site, the presence of a priming loop, the sites of viral RNA binding, and the sites of channels for template, NTP and capped-primer entry, as well as template and product exit. All these features of the influenza virus RNA polymerase are putative targets for small-molecule inhibitors (see the figure, part a; a cartoon model of the influenza A virus polymerase structure (Protein Data Bank (PDB) entry 4WSB)). Structural studies of the influenza virus polymerase in complex with other viral factors, such as nucleoprotein (NP), or host factors are likely to reveal interaction interfaces that could also be targeted. For example, the site of the interaction with the C-terminal domain (CTD) of the cellular DNA-dependent RNA polymerase II (Pol II) large subunit is currently unknown, but it could represent an attractive target for an antiviral. Similarly, the host protein ANP32A has been shown to interact with the influenza virus polymerase, and it is a crucial factor for the replication activity that is linked to the PB2 627-domain 121, 122 . Uncovering the mode of interaction of ANP32A with the viral polymerase could reveal yet another site in the polymerase that could be targeted. Disruption of heterotrimer assembly is an alternative strategy for the development of antivirals that target the influenza virus polymerase (see the figure, part b; a cartoon model of the influenza A virus polymerase structure (PDB entry 4WSB) highlighting the interactions between the PB1 N-terminal helix (PB1-N) and three helices of the C-terminal PA domain (PA-C), as well as those between the PB1 C terminus and PB2 N terminus; additional interfaces revealed by the structures of the heterotrimeric polymerase complex are also highlighted). Studies have so far focused on the interaction of the PA C terminus with the PB1 N terminus, and the interaction between the PB1 C terminus and PB2 N terminus, as revealed by previous structural analyses of isolated domains [20] [21] [22] . These interactions have been targeted by antiviral peptides, peptidomimetics or small molecules [142] [143] [144] [145] [146] [147] [148] [149] . The structures of the complete polymerase heterotrimer reveal numerous additional interaction interfaces, such as the interface between PB2 helix 6 and PB1 helices 17 and 19 of the PB1 thumb subdomain, and such interfaces could be targeted using similar strategies. In addition, potential antivirals could target interfaces that are present in only one of the various conformational states that have been observed in the crystal structures. One example is the interaction between the penultimate helix of PB1 and helix 4 of the PA endonuclease domain, which is evident only in the polymerase bound to a genomic negative-sense viral RNA (vRNA) promoter, and further examples are the various interdomain interactions in the C-terminal two-thirds of PB2. 'Locking' the polymerase in a particular conformation using a small molecule might be yet another viable strategy for the development of antivirals. Nature Reviews | Microbiology Interactions between the viral and host transcriptional machineries provide the viral polymerase with a platform to coordinate cap-snatching, transcription, replication and RNA processing, as well as mRNA and vRNA nuclear export 54, 80, 104 . Conversely, these interactions might also provide the virus with an opportunity to interfere with host gene expression, inhibiting the expression of antiviral host genes. The viral protein NS1 is well known to interfere with the 3′ end formation in host mRNAs through an interaction with the cellular poly adenylation machinery 125 . In addition, interaction of the viral RNA polymerase with Pol II and cleavage of nascent capped host RNA is presumably important for the inhibition of host gene expression, including antiviral host genes 112, 126 . Moreover, degradation of the large subunit of Pol II has also been observed in cells that are infected with influenza viruses and has been associated with increased influenza virus pathogenicity in mice 127, 128 .
Outlook and conclusions
The recently published high-resolution structures of the influenza virus RNA polymerase provide unprecedented insights into the mechanisms of this molecular machine. The PB1 subunit together with the C-terminal domain of PA (or P3) and the N-terminal one-third of PB2 form the core of the polymerase. The architecture of this core is similar to that of other viral RNA-dependent RNA polymerases. The core encompasses the polymerase active site, which is connected to the exterior by several channels, including channels for template and NTP entry as well as those for template and product exit. Near the active site, the priming loop is essential for primerindependent terminal initiation on the vRNA template, but is not required for primer-dependent transcription or, surprisingly, for primer-independent internal initiation on the cRNA template. The core of the polymerase is decorated by several flexible domains, including the PB2 cap-binding and PA (or P3) endonuclease domains. These domains can be arranged in two different conformations that either enable or are incompatible with cap-snatching, which suggests that the polymerase exists in several functional states. These functional states are controlled by the association of the polymerase with viral RNA and possibly other viral and host factors.
Although unprecedented progress has been made in understanding the structure and function of the influenza virus RNA polymerase, many long-standing questions remain unanswered. The available crystal structures have provided insights into subunit and domain organization. However, this is only a starting point for further investigations into how this complex machine functions. For example, none of the available structures shows the polymerase in an active conformation with template RNA in the active site, and we cannot rule out the possibility that the polymerase adopts different conformations during initiation and elongation. Likewise, the conformation of the terminating polymerase might be different. Further structural analysis by crystallography and new powerful cryo-EM technologies will be required to visualize other functional states of the influenza virus polymerase -for example, in complex with RNA templates, RNA primers and incoming nucleotides during initiation, elongation and termination.
The trans-acting and trans-activating replication models discussed above indicate that multiple polymerases are required for this process, and although oligomerization of polymerase heterotrimers and subcomplexes has been observed 25, 129 , there is virtually no information available about how these polymerases might interact. Single-molecule techniques could greatly increase our understanding of the mechanics and kinetics of the polymerase during transcription and replication, through the use of fluorescently labelled polymerase molecules and RNA templates 35 . Another avenue of interest concerns the location, host interactions and dynamics of RNPs in the nucleus. Importantly, it remains unclear whether RNPs associate with specific nuclear sites for transcription and genome replication. Do these two processes occur at the same site or at different sites? It will be important to determine how host factors, such as ANP32A, contribute to polymerase function and host adaptation. It will be equally important to study what cellular factors participate in the assembly of vRNPs and viral mRNPs, and also in their nuclear export. Ultimately, understanding these molecular mechanisms will not only improve our basic scientific knowledge of the workings of an important human and animal pathogen, but also contribute to our understanding of virulence and adaptation mechanisms of influenza viruses. Furthermore, understanding how the influenza virus RNA synthesis machine works at the molecular level and discerning its interaction with viral and host factors might lead to the identification of targets that could be exploited for the development of drugs to prevent or treat influenza virus infections
